Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,300
Closed -$109K 294
2025
Q3
$109K Hold
1,300
0.02% 284
2025
Q2
$103K Hold
1,300
0.02% 280
2025
Q1
$117K Hold
1,300
0.02% 274
2024
Q4
$129K Hold
1,300
0.02% 286
2024
Q3
$148K Buy
+1,300
New +$154K 0.03% 293

Other funds holding MRK

Insight Advisors's MRK Position: Q1 2026 in Review

Insight Advisors reduced its Merck (MRK) stake by 1.2% in Q1 2026, selling an estimated $27.5K and leaving 20,086 shares worth $2.42M. The position accounts for 0.46% of the portfolio, ranked #29.

Insight Advisors first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.07M in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Insight Advisors held 20,086 shares of Merck worth $2.42M as of Q1 2026.
  • Insight Advisors sold 238 Merck shares in Q1 2026, an estimated $27.5K.
  • Merck made up 0.46% of Insight Advisors's portfolio in Q1 2026, its #29 holding.
  • Insight Advisors first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • Insight Advisors's Merck position peaked at $3.07M in Q2 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Insight Advisors's 13F filing for Q1 2026, filed 12 May 2026.